Impact of Antiviral Therapy on Gastroesophageal Varices.

Conditions:   Chronic Hepatitis C;   CirrhosisInterventions:   Drug: Pegylated interferon alfa-2a + Ribavirin;   Drug: Pegylated interferon alfa-2a + Ribavirin + Boceprevir;   Drug: Pegylated interferon alfa-2a + Ribavirin +Telaprevir;   Drug: Ledipasvir/Sofosbuvir;   Drug: Ombitasvir/paritaprevir/ritonavir+Dasabuvir;   Drug: Daclatasvir+Sofosbuvir;   Drug: Simeprevir+SofosbuvirSponsor:   Parc de Salut MarActive, not recruiting - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials